Ricerca

Pubblicazioni IRIS

• Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
  Anno: 2025
• JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib
  Anno: 2025
• Applications, challenges and future directions of artificial intelligence in cardio-oncology
  Anno: 2025
• Biological modifications of the immune response to COVID-19 vaccine in patients treated with anti-CD20 agents and immune-checkpoint inhibitors.
  Anno: 2024
• Comprehensive analysis of plasma methylome reveals distinct patterns of methylation changes between responders and non-responders to neoadjuvant chemotherapy in breast cancer
  Anno: 2024